Skip to content

Respiratory Virus Infections in Acutely Hospitalized Adult Patients With Pulmonary and Extrapulmonary Complications

Respiratory Virus Infections in Acutely Hospitalized Adult Patients With Pulmonary and Extrapulmonary Complications

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03816059
Enrollment
200
Registered
2019-01-25
Start date
2019-02-12
Completion date
2020-04-20
Last updated
2020-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndrome, Lung Disease, Respiratory Virus Infection, Stroke

Keywords

Respiratory virus infection, Extrapulmonary complications, Myocardial infarction, Asthma, Bronchiectasis, Chronic obstructive pulmonary disease, Cerebrovascular disease

Brief summary

Respiratory virus infections are one of the major causes of hospitalizations, and outbreaks of respiratory virus infection have led to severe economic loss. In addition to pulmonary complications, respiratory viruses can also lead to non-pulmonary complications. However, many previous studies on the complications of respiratory viruses are retrospective in nature, and therefore many patients with respiratory virus infection may not be tested. Furthermore, these studies did not take into account that respiratory viruses can be found in some asymptomatic individuals. The aim of this study is to capture the burden of respiratory viruses in patients with acute pulmonary and extrapulmonary complications. We will recruit patients admitted to our hospital with acute coronary syndrome, stroke and exacerbation of underlying lung diseases. We will collect saliva from these patients and test for respiratory viruses. As controls, we will recruit asymptomatic patients at the out-patient clinic for follow up of chronic heart, lung or neurological diseases. We anticipate that this study will greatly enhance our understanding of the epidemiology of respiratory viruses in acutely hospitalized patients. Our findings will be important for clinicians, public health practitioners and scientists.

Detailed description

Respiratory viruses cause severe infections, and contribute to a substantial number of hospitalizations, admission to intensive care units and deaths. Many hospitalizations due to respiratory virus infection are related to pneumonia or exacerbation of chronic lung disease. In addition, many hospitalizations are related to extrapulmonary complications, such as acute coronary syndrome or stroke. Previous studies have reported the incidence of respiratory viruses among patients with pulmonary complications, or the association of respiratory viruses with acute coronary syndrome or stroke. However, there are several problems associated with these studies. First, many of these studies are retrospective in nature, and therefore testing was only performed in selected patients with respiratory symptoms. Hence, many patients without respiratory symptoms were not recruited. Second, respiratory virus can be detected in some asymptomatic individuals. Therefore, the presence of respiratory virus may be an incidental finding rather than the cause of the complication. Third, many studies only focus on a few respiratory viruses, especially on influenza virus. This study aims to address these issues. The investigators propose to conduct a prospective cohort study. The investigators will recruit hospitalized adult patients with exacerbation of underlying lung disease, acute coronary syndrome or stroke. As controls, the investigators will recruit outpatients follow-up for chronic heart disease, chronic lung disease or neurological conditions. The investigators will collect saliva from study participants and perform respiratory virus testing using a multiplex PCR panel. Previous studies have shown that there is a high concordance between results from respiratory virus testing on saliva and nasopharyngeal specimens. The investigators will also use a standardized questionnaire to collect information regarding symptoms. This study will provide accurate data on the epidemiology of respiratory viruses in pulmonary and extrapulmonary complications.These data are important for clinicians, public health practitioners and scientists.

Interventions

DIAGNOSTIC_TESTRespiratory virus testing

All patients will be tested for respiratory viruses

Sponsors

The University of Hong Kong
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

(For hospitalized patients) 1. Admitted to the acute medical ward of Queen Mary Hospital via the accident and emergency department 2. Aged 18 years or above 3. Hospitalized for less than 24 hours at the time of recruitment 4. Presented with exacerbation of underlying lung disease, acute coronary syndrome or stroke 5. Competent and agree to provide written informed consent

Exclusion criteria

(For hospitalized patients) 1. Admitted to any hospitals in the past 14 days 2. Respiratory virus testing performed in the past 14 days 3. Antiviral against respiratory virus given within the past 14 days 4. Not sufficient saliva Inclusion Criteria: (For out-patients) 1. Aged 18 years or above 2. Follow-up at out-patient clinic or at the physiotherapy department of Queen Mary Hospital 3. Competent and agree to provide written informed consent

Design outcomes

Primary

MeasureTime frameDescription
Incidence of respiratory viruses2 daysIncidence of respiratory viruses

Secondary

MeasureTime frameDescription
Length of stay in general medical ward1 monthLength of stay in general medical ward
Length of stay in high dependency unit1 monthLength of stay in high dependency unit
Length of stay in intensive care unit1 monthLength of stay in intensive care unit
Proportion of patients requiring oxygen supplementation1 monthProportion of patients requiring oxygen supplementation
Proportion of patients requiring positive pressure ventilation1 monthProportion of patients requiring positive pressure ventilation
Proportion of patients requiring intubation1 monthProportion of patients requiring intubation
Proportion of patients admitted to intensive care unit1 monthProportion of patients admitted to intensive care unit
Proportion of patients admitted to coronary care unit1 monthProportion of patients admitted to coronary care unit
Length of hospital stay1 monthLength of hospital stay
Proportion of patients who die during hospitalization1 monthProportion of patients who die during hospitalization
White blood cell on admission1 dayWhite blood cell count in blood (x 10\^9 cells/L)
Platelet count upon admission1 dayPlatelet count in blood (x 10\^9 cells/L) upon admission
Alanine aminotransferase upon admission1 dayThe level of alanine aminotransferase in blood (U/L)
Creatinine on admission1 dayThe level of creatinine in blood (umol/L) upon
Blood culture result3 daysThe result of blood culture
Sputum culture result3 daysThe result of sputum culture
Proportion of patients with pneumonia1 monthProportion of patients with pneumonia
Proportion of patients admitted to high dependency unit1 monthProportion of patients admitted to high dependency unit

Countries

Hong Kong

Contacts

Primary ContactKelvin To, MD
kelvinto@hku.hk(852)-22552413

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026